Consensus Recommendations for Management and Counseling of Adverse Events Associated With Lorlatinib: A Guide for Healthcare Practitioners.
Adv Ther
; 37(6): 3019-3030, 2020 06.
Article
in En
| MEDLINE
| ID: mdl-32399810
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protein-Tyrosine Kinases
/
Carcinoma, Non-Small-Cell Lung
/
Lactams, Macrocyclic
/
Protein Kinase Inhibitors
/
Lung Neoplasms
Type of study:
Guideline
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Adv Ther
Journal subject:
TERAPEUTICA
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
United States